Home/Insights/Where a Clinic Should Start Reviewing Vendor Costs
Vendor Cost ManagementCura Insight
Where Should a Veterinary Clinic Start When Reviewing Vendor Costs?
The largest vendor category is not always the best place to begin. A more useful approach considers both the economic opportunity and the clinic's ability to act on it.
Brian Fosselman, Founder, Cura Veterinary PartnersAugust 27, 202610 minute read
Veterinary practices can have dozens of recurring vendor relationships spanning pharmaceuticals, distribution, reference laboratories, insurance, software, payment processing, communications, waste services, medical supplies, nutrition, and other operating needs. Manufacturer programs, buying groups, rebates, service agreements, and contracts with different renewal schedules add another layer of complexity.
One intuitive response is to rank those relationships by annual spend and start at the top. There is good reason to pay attention to the largest expense categories because a modest percentage improvement on a large spend base can create considerably more value than a significant percentage improvement on a small one.
Annual spend, however, answers only part of the question. A large category under a recently negotiated multi-year agreement may offer limited near-term flexibility, while a somewhat smaller category approaching renewal may have several credible alternatives, recent price increases, or commercial terms that have not been tested for years. Another category may look attractive financially but require enough clinical or operational disruption that pursuing the opportunity today would make little sense.
A clinic can still establish visibility across its entire vendor spend profile. The management challenge is deciding where deeper analysis and action should come first, which requires looking beyond spend alone and considering where meaningful economic opportunity intersects with a realistic ability to act.
What clinic owners should know
Start with the full vendor landscape, not a predetermined target. Understanding the clinic's major spend categories provides the context needed to decide where deeper review is warranted.
Annual spend matters, but it is not a complete prioritization rule. Contract timing, recent price movement, competitive alternatives, pricing complexity, and prior benchmarking can materially change which category deserves attention first.
Economic opportunity and actionability should be considered together. A category becomes a stronger near-term review candidate when the potential financial value is meaningful and the clinic has a realistic path to evaluate, negotiate, or change the arrangement.
Renewal and termination windows can change the order of work. A category approaching a contractual decision point may deserve earlier attention than a larger category with little near-term flexibility.
Operational and clinical consequences belong in the analysis. A theoretical savings opportunity is less attractive when implementation effort, workflow disruption, service risk, or clinical preferences outweigh the likely financial benefit.
Prioritization does not mean ignoring the rest of the spend profile. A comprehensive review can evaluate the entire vendor landscape while directing the greatest analytical and implementation effort toward the categories where additional work is most justified.
Industry Context
Patient visits remain under pressure
Vetsource's 2026 veterinary industry research analyzed data from 6,451 U.S. veterinary practices and found that visits declined 3.1% in 2025, following declines of 1.4% in 2023 and 2.6% in 2024. Its research also found that revenue remained slightly positive even as patient visits continued to fall.
Vendor-cost management is not a substitute for patient growth, appropriate pricing, clinical quality, or client retention. Still, when visit growth cannot be taken for granted, practices have additional reason to manage the economics that are more directly within their control. Recurring vendor spend is one of those areas, and the first challenge is deciding where management attention can be used most effectively.
Prioritization works best when it begins with broad visibility. A practice reviewing only the vendor that recently raised prices may miss a larger opportunity elsewhere, while starting only with contracts approaching renewal may overlook categories with no formal agreement at all. Looking exclusively at the largest invoices can create a different problem by favoring categories that are economically important but difficult to influence today.
A more useful starting point is a category-level view of the clinic's recurring vendor spend. That does not require every category to receive the same depth of analysis at the same moment. It means understanding enough of the overall landscape to compare categories intelligently and identify where further work is most likely to be worthwhile.
For many practices, the initial picture might include pharmaceuticals and medical supplies, distribution, reference laboratory services, prescription diets, insurance, payment processing, communications, software, waste services, equipment-related agreements, and other recurring operating expenses. The exact categories will vary by clinic, but the underlying question is similar: where is there enough potential value, and enough ability to act, to justify deeper attention now?
Annual spend matters, but it is only one dimension
Annual spend belongs near the beginning of any prioritization exercise because the size of the spend base affects the magnitude of the possible result. Consider two illustrative categories: a clinic spends $200,000 annually in Category A and $25,000 in Category B. Even a relatively modest improvement in Category A could exceed a much larger percentage improvement in Category B, so ignoring spend would make little economic sense.
The limitation comes from treating spend as the only variable. Suppose Category A was competitively reviewed six months ago, is operating under favorable terms, has strong service performance, and is subject to a multi-year agreement. Category B, meanwhile, has not been reviewed in five years, recently experienced another price increase, has several credible alternatives, and is approaching renewal. Category A remains economically important, but the circumstances may make Category B the more productive place to focus first.
Review priority depends on both economic opportunity and actionability
A practical way to compare vendor categories is across two dimensions. Economic opportunity reflects whether enough potential financial value exists to justify meaningful attention. Annual spend is part of that assessment, but so are recent price increases, pricing complexity, fee structures, rebates, purchasing patterns, and indications that current economics may no longer reflect the market.
Actionability reflects how realistic it is for the clinic to do something with that opportunity in the near term. Contract timing, termination provisions, credible alternatives, incumbent negotiation opportunities, information availability, and implementation requirements can all affect that assessment.
A category with substantial economic opportunity but limited actionability may warrant analysis and preparation without becoming the first active negotiation. A category that is easy to address but represents relatively little financial value may also rank behind more consequential work. Categories that combine meaningful opportunity with a practical path to action generally warrant the closest near-term attention.
Exhibit 1
Vendor Review Prioritization Matrix
Where economic opportunity and actionability intersect.
Outer ring = renewal or notice window approaching.
Illustrative framework. The appropriate position of any vendor category depends on the clinic's individual economics, agreements, alternatives, operational requirements, and timing.
Source: Cura Veterinary Partners.
The matrix is intended to prioritize review effort, not predict the final recommendation. A category placed in the upper-right quadrant does not automatically require a vendor change. A closer review may conclude that the incumbent should remain unchanged, that existing terms should be renegotiated, that only part of the arrangement should change, or that a competitive market check is warranted. The priority decision determines where to investigate. It does not predetermine the outcome.
Six questions can help determine what deserves attention first
A clinic does not need a complicated scoring model to form an initial view. Six practical questions can usually provide enough information to distinguish categories that warrant immediate attention from those that can reasonably be sequenced later.
1. Is the annual spend large enough to create a meaningful economic opportunity?
Larger categories deserve attention because relatively small changes in unit pricing, fees, rebates, service levels, or purchasing structure can have a meaningful financial effect. Spend should still be considered in context, since a high-spend category that has recently been competitively tested may warrant less immediate attention than its size alone would suggest.
2. Is there evidence that the current economics deserve another look?
Recent price increases are one signal, but they are not the only one. Pricing that is difficult to reconcile, layered fees, complex rebate structures, inconsistent discounts, changing purchasing patterns, or an arrangement that has simply continued for years without review may all justify closer analysis.
A category does not need to look obviously overpriced before it deserves benchmarking. In many cases, the purpose of a review is simply to determine whether the current economics remain competitive.
3. Is a renewal, termination, or other decision point approaching?
Timing can materially affect priority because commercial options may disappear if a clinic begins its review too late. An agreement that requires advance notice to terminate, for example, may effectively roll into another term before the practice has enough information to evaluate alternatives.
An upcoming renewal can also create a natural point to benchmark pricing, reconsider terms, or negotiate with the incumbent. That timing advantage can cause a somewhat smaller category to move ahead of a larger one in the review sequence.
4. Are there credible alternatives or meaningful negotiation levers?
A theoretical market alternative is not necessarily a practical one. The relevant question is whether the clinic has options that could realistically meet its clinical, operational, service, and economic requirements.
Some categories may have several credible suppliers, while local availability, integrations, service expectations, clinician preferences, or product requirements narrow the field in others. Alternatives also do not need to result in a vendor change. Understanding what else is available can provide useful information for evaluating and negotiating the current arrangement.
5. How long has it been since the category was last benchmarked?
A long-standing vendor relationship is not inherently a poor one. Reliable service, familiarity, and trusted relationships can create substantial value for a practice, and there is little benefit in introducing disruption merely because an agreement has been in place for several years.
Markets still change over time. Pricing structures evolve, competitors enter or leave categories, technology improves, practice needs shift, and agreements that were attractive several years ago may no longer compare the same way. The longer a meaningful category has gone without an external market check, the stronger the case may be for understanding where the current arrangement stands today.
6. Would the likely benefit justify the clinical and operational burden?
Not every theoretically available dollar should be pursued. Changing an arrangement may require staff training, new workflows, system integrations, inventory changes, clinician adjustment, client communication, administrative coordination, or a period of operational risk.
Those costs do not always appear neatly on an invoice, but they remain part of the economics. A well-prioritized review therefore considers the probable financial benefit alongside the effort and risk required to realize it. Sometimes the appropriate conclusion is that an opportunity exists but is not worth pursuing.
Exhibit 2
Six Questions for Prioritizing a Vendor Review
Move from full spend visibility to focused analysis.
Economic Opportunity
1
Is annual spend large enough to matter?
2
Do pricing, fees, rebates, or recent increases warrant another look?
3
Has enough time passed since the category was last benchmarked?
Actionability
4
Is a renewal, termination, or other decision point approaching?
5
Are credible alternatives or negotiation levers available?
6
Is the likely benefit sufficient to justify implementation effort and operational risk?
Priority Review
Categories that combine meaningful economic potential with a practical path to action deserve the deepest near-term attention.
The questions are screening considerations, not a mechanical scoring formula. Clinic-specific circumstances should determine the final priority.
Source: Cura Veterinary Partners.
What prioritization can look like in practice
Consider an illustrative independent veterinary clinic reviewing five vendor categories. Its largest category has substantial annual spend, but the clinic conducted a competitive review recently and entered a new agreement with acceptable economics and strong service performance. The category remains important, although there may be little reason to reopen it immediately.
A second category is smaller but approaching renewal within several months. Pricing has increased, the clinic has not benchmarked the relationship recently, and several credible alternatives exist. A third category has moderate spend, relatively transparent economics, multiple alternatives, and limited implementation burden. Depending on what an initial market check reveals, either could reasonably move ahead of the clinic's largest category.
A fourth category is easy to change but represents very little annual spend, making the absolute value potentially too small to justify immediate attention. The fifth has substantial spend and possible economic upside, but a change would affect clinically important workflows and a trusted service relationship. That category may still deserve careful analysis, but service quality and implementation risk belong alongside the potential savings in the decision.
The point is not that any one of these categories should be ignored. A comprehensive review can account for all five while using different levels of effort and different timelines based on what the analysis shows.
Priorities should be allowed to change
An initial ranking is useful, but it should not become rigid. A category that appears less actionable may move higher when an agreement is located and an approaching termination window is discovered, while another may fall lower after invoice analysis confirms favorable pricing.
Market research can also reveal more or fewer alternatives than expected, and an apparent savings opportunity can become less attractive once the implementation requirements are understood. For clinics conducting their own reviews, this is a reason not to spend excessive time trying to create a perfect ranking before substantive analysis begins. Establish enough visibility to identify likely priorities, begin investigating them, and adjust the sequence as better information becomes available.
Where Cura fits
Cura Veterinary Partners approaches vendor-cost review by first establishing visibility across a clinic's broader recurring vendor spend rather than assuming in advance which category or vendor needs to change. From that baseline, Cura evaluates where deeper attention is warranted based on category economics, existing pricing and contract structure, upcoming decision points, market alternatives, operational requirements, and the clinic's own preferences.
That work can include invoice and spend analysis, contract review, pricing and fee reconciliation, market benchmarking, competitive requests, incumbent negotiations, implementation planning, and savings verification. Where appropriate and authorized by the clinic, Cura can also coordinate directly with vendors and other relevant parties to reduce the administrative burden on practice leadership.
Reviewing the full spend profile does not mean every category must produce a savings initiative or vendor change. Some may warrant immediate action, others may be better addressed closer to a future renewal, and some may prove competitive enough to leave alone. The purpose is to understand where the opportunities actually are and direct the greatest effort toward the areas where further work is justified.
Cura's perspective
A clinic reviewing vendor costs should have visibility across the entire vendor landscape, but that does not require giving every category the same analytical priority or pursuing every opportunity at once. Annual spend provides an important starting point, and the picture becomes more useful when spend is considered alongside recent pricing changes, contract timing, market alternatives, prior benchmarking, implementation burden, and the operational or clinical importance of the relationship.
That combination helps distinguish categories that are simply large from categories where there is both a meaningful economic question and a realistic opportunity to address it. For an independent practice with limited management capacity, thoughtful sequencing can make a broad vendor review more efficient without making it less comprehensive. The clinic still sees the full picture while spending the most time where closer analysis is most likely to be useful.
Could a structured vendor review help your clinic decide where to start?
If your clinic has dozens of vendor relationships and is unsure which categories deserve attention first, Cura can help evaluate the full vendor spend profile, identify priority opportunities, and determine where deeper review is most likely to create meaningful value.
Brian Fosselman is the founder of Cura Veterinary Partners. His background includes management consulting work focused on procurement-related cost optimization, strategic negotiations, and business performance improvement. Through Cura, he helps independent veterinary clinics evaluate vendor spend, negotiate stronger agreements, and improve cash flow while limiting additional demands on clinical teams.